| Value | ₹65.00 Cr |
|---|
BSE filing, NSE: IMAGICAA. Summary written from the filing by ALFA Finder's alert engine.
Imagicaaworld Entertainment Ltd: key numbers
- Share price
- ₹41.05
- Market cap
- ₹2,419 Cr
- Revenue (annual)
- ₹373.9 Cr
- Net profit (annual)
- ₹0.64 Cr
- P/E (TTM)
- 174.1×Sector 33.4×
- Promoter holding
- 73.95%-0.07% QoQ
- FII holding
- 0.17%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Imagicaaworld Entertainment Ltd
All →Imagicaaworld Entertainment Annual General Meeting
Imagicaaworld seeks postal ballot approval to sell Hotel Novotel Imagicaa to Juniper Hotels for ₹248 Crore. A special resolution is required for the slump sale under Section 180(1)(a).
- Value
- ₹248.0 Cr
Imagicaaworld Entertainment Merger & Restructuring
Imagicaaworld seeks postal-ballot approval to sell Hotel Novotel Imagicaa on a slump-sale basis under Section 180(1)(a) and SEBI Reg 37A. No sale price is disclosed in the notice.
Imagicaaworld Entertainment Business Update
Imagicaaworld reported Q2 FY27 footfalls of 2.1 lakh, down 6% YoY. Updates include Novotel sale, full warrant conversion, and acquisition of Shanku's Water Park.
Imagicaaworld Entertainment Management Change
Mr. Suresh Bharathwaj has completed his second term as an Independent Director of Imagicaaworld Entertainment Limited, effective October 17, 2026. He ceases all associated committee roles.
Imagicaaworld Entertainment Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
Imagicaaworld Entertainment Merger & Restructuring Worth ₹248 Cr
Imagicaaworld Entertainment is selling its Hotel Novotel Imagicaa undertaking to Juniper Hotels for Rs. 248 Crore, subject to shareholder approval.
- Value
- ₹248.0 Cr
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr